Yahoo Canada Web Search

Sign In

  1. Ad

    related to: viatris spinoff from pfizer

  2. Astellas Oncology Information - Patient Support & Resources

    Our partnerships and therapies strive to change cancer care and the lives of patients. See how we tackle oncology's toughest challenges to reimagine the patient experience.

Search results

    • Organon's Valuation Is Not Expensive

      Organon's Valuation Is Not Expensive

      GuruFocus.com via Yahoo Finance Canada· 5 months ago

      Organon & Co. (NYSE:OGN), one of the largest pharmaceutical companies in the world, formed as a result of a spin-off from Merck (NYSE:MRK) and...